A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
Sign Up to like & getrecommendations! Published in 2017 at "Cold Spring Harbor Molecular Case Studies"
DOI: 10.1101/mcs.a001396
Abstract: Pleomorphic xanthoastrocytoma (PXA) is a World Health Organization (WHO) Grade II glioma occurring primarily in children and young adults. Most PXAs harbor the known activating mutation BRAF V600E. We report a case of locally recurrent… read more here.
Keywords: tmem106b braf; braf; braf fusion; pleomorphic xanthoastrocytoma ... See more keywords